在Acinetobacter baumannii的临床菌株中的CRISPR-Cas系统:一个in-silico分析
Arturo Martínez-Trejo1, Juan Manuel Ruiz-Ruiz2, Luis Uriel Gonzalez-Avila1
1Laboratorio de Investigación Clínica y Ambiental, Departamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
Letters in applied microbiology
|January 11, 2024
概括
在Acinetobacter baumannii中的CRISPR-Cas系统可能有助于它抵抗菌体. 这项研究分析了基因组,发现CRISPR-Cas系统可能与耐药性基因有关,但与毒性无关.
科学领域:
- 微生物学 微生物学
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- Acinetobacter baumannii表现出高抗微生物耐药性,通常与遗传物质的获取有关.
- 集群定期间隔的简短的Palindromic重复 (CRISPR) -Cas系统参与管理外来遗传元素并影响细菌生理学.
研究的目的:
- 调查CRISPR-Cas系统在Acinetobacter baumannii的临床菌株中的存在,分布和特征.
- 探索CRISPR-Cas系统与抗菌素耐药性和病毒性基因的潜在关联.
主要方法:
- 来自NCBI数据库的91个完全组装的Acinetobacter baumannii基因组的in-silico分析.
- 生物信息工具被用来识别和描述CRISPR-Cas系统的子类型,架构和原型.
- 间隔序列的分析和与耐药性和毒性基因的相关性.
主要成果:
- 在分析的基因组中,CRISPR-Cas系统的I-F1亚型被确定,其架构和原型的变化.
- 观察到CRISPR-Cas系统与抗菌素耐药性基因之间存在潜在的关联.
- 在CRISPR-Cas系统和毒性决定因素之间没有发现显著的关联.
- 间隔器序列分析表明,它在保护菌体感染方面发挥着作用.
结论:
- 在临床Acinetobacter baumannii菌株中,CRISPR-Cas系统,特别是I-F1亚型存在并可变.
- 该系统可能对菌体感染起着保护作用,并可能与抗菌素耐药性有关.
- 需要进一步的研究来阐明CRISPR-Cas系统在Acinetobacter baumannii病原和耐药性的精确机制和影响.
相关概念视频
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
CRISPR
51.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.1K


